Stimulating DDX3 expression by serotonin 5-HT receptor 7 through phosphorylation of p53 via the AC-PKA-ERK signaling pathway
Related Experiment Video
Updated: Jan 23, 2026

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
Li-Jung Kang1, Khoa V A Nguyen1, Sanung Eom1
1Department of Biotechnology, Chonnam National University, Gwangju, Republic of Korea.
Abstract:
DDX3 is a host viral factor that can inhibit the hepatitis B virus-induced innate immune responses. In this study, the 20 bioactive compounds have screened the effects on DDX3 and we found that 5-HT upregulated DDX3 promoter activity via the 5-HT7 receptor on liver hepatocellular cells (HepG2 cells) by using a luciferase assay, reverse transcription-polymerase chain reaction analysis, and Western blot analysis. Furthermore, we are trying to elucidate the pathways involved in the stimulating effect of 5-HT on DDX3 expression to induce innate immune responses against hepatitis B virus infection. A knockdown of the 5-HT7 receptor by transfection si-5-HT7 receptors or si-control into HepG2 cells treated by 5-HT (or 5-HT plus agonist) confirmed the role of the 5-HT7 receptor in DDX3 expression. The IFN-β-Luc expression and level of hepatitis B virus surface Antigen (HBsAg) showed that DDX3 mediated by the 5-HT7 agonist (AS-19) increased IFN-β expression and inhibited HBV replication. Luciferase assays showed the involvement of 5-HT7 receptors in DDX3 expression via cAMP/AC/PKA pathways by using protein kinase A (PKA) and adenylyl cyclase inhibitor (MDL 12330A). AS-19 mediated DDX3 promoter activated PKA extracellular signal-regulated kinase ERK signaling the p53 phosphorylation (-1080/-1070) resulted in upregulation of DDX3 promoter transactivation via the 5-HT7 receptors agonist. Overall, 5-HT7 was found to be a new potential target to inhibit hepatitis B infection by activating AC/PKA/ERK pathways by phosphorylating p53 via the 5-HT7 agonist response by mediating DDX3 expression.
Insights
Serotonin 5-HT7 receptor activation upregulates DDX3 expression, enhancing innate immunity against Hepatitis B virus (HBV). This pathway, involving cAMP/AC/PKA/ERK signaling and p53 phosphorylation, offers a novel therapeutic target for HBV infection.
Area of Science:
- Virology
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Hepatitis B virus (HBV) infection poses a significant global health challenge.
- DDX3 is a host factor crucial for innate immune responses against viral pathogens.
- Understanding host-pathogen interactions is key to developing antiviral strategies.
Purpose of the Study:
- To investigate the effect of bioactive compounds on DDX3 expression.
- To elucidate the role of the serotonin 5-HT7 receptor in regulating DDX3.
- To explore the signaling pathways mediating 5-HT-induced DDX3 expression and its antiviral effects against HBV.
Main Methods:
- Screening of 20 bioactive compounds for effects on DDX3.
- Luciferase assays, RT-PCR, and Western blot analysis to assess DDX3 promoter activity and expression.
- siRNA-mediated knockdown of 5-HT7 receptor and pharmacological inhibition of signaling pathways (cAMP/AC/PKA/ERK).
Main Results:
- 5-HT upregulated DDX3 promoter activity via the 5-HT7 receptor in HepG2 cells.
- 5-HT7 receptor activation by agonist AS-19 increased IFN-β expression and inhibited HBV replication.
- The 5-HT7 receptor mediates DDX3 expression through cAMP/AC/PKA/ERK pathways, involving p53 phosphorylation.
Conclusions:
- The 5-HT7 receptor is a novel target for enhancing innate immune responses against HBV.
- Activation of the 5-HT7 receptor promotes DDX3 expression and antiviral activity via specific signaling cascades.
- This study identifies a promising therapeutic avenue for managing Hepatitis B virus infection.
More Related Videos
11:00Photostimulation by Femtosecond Laser Activates Extracellular-signal-regulated Kinase ERK Signaling or Mitochondrial Events in Target Cells
Published on: July 6, 2019
11:48Grafting of Beads into Developing Chicken Embryo Limbs to Identify Signal Transduction Pathways Affecting Gene Expression
Published on: January 17, 2016
Related Concept Videos
Intracellular Signaling Cascades
Insulin: The Receptor and Signaling Pathways
Endocrine Signaling
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...